A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score.

J Clin Med · 2026 · PMC13116748 · PMID 42074920

Europe PMC DOI

hedged sentence

0.1360

closest p · 2.7× alpha

0.1360

boldest claim

The sentences

did not reach statistical significancep = 0.136not close (p > 0.1)

Although the Ki-67 percentage was higher in the pCR group, the difference did not reach statistical significance (52.5% vs. 45.1%; p = 0.136).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.